A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation
Conditions: Early-stage Triple-negative Breast Cancer With BRCA1/2 Mutations Interventions: Other: no intervention Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | China Health | Genetics | Hospitals | Research | Study